Test ID IABCS B-Cell Phenotyping Profile for Immunodeficiency and Immune Competence Assessment, Blood
Useful For
Screening for common variable immunodeficiency and hyper-IgM syndromes
Assessing B-cell subset reconstitution after stem cell or bone marrow transplant
Assessing response to B-cell-depleting immunotherapy
This test is not indicated for the evaluation of lymphoproliferative disorders (eg, leukemia, lymphoma, multiple myeloma).
Method Name
Flow Cytometry
Reporting Name
Immune Assessment B Cell Subsets, BSpecimen Type
Whole Blood EDTAOrdering Guidance
The IABCS is a panel test. This test requires two separate whole blood EDTA specimens at two different transport temperatures: one ambient and one refrigerate.
The TBBS / Quantitative Lymphocyte Subsets: T, B, and Natural Killer (NK) Cells, Blood is automatically performed, a separate order is not required.
If only an ambient EDTA specimen is received, only the TBBS / Quantitative Lymphocyte Subsets: T, B, and Natural Killer (NK) Cells, Blood will be performed. If only a refrigerate EDTA sample is received, this test will be canceled and converted to RBCS / Relative B-Cell Subset Analysis Percentage, Blood, which provides the relative B-cell subset values without quantitation.
This test is a screening test and further analyses will be required to complete a diagnostic workup for hyper-IgM (XHIM / X-Linked Hyper IgM Syndrome, Blood and CD40 / B-Cell CD40 Expression by Flow Cytometry, Blood).
Shipping Instructions
Testing performed Monday through-Friday. Specimens not received by 4pm (CST) on Friday may be canceled.
Samples arriving on the weekend and observed holidays may be canceled.
Collect and package specimens as close to shipping time as possible.
It is recommended that specimens arrive within 24 hours of collection.
Necessary Information
1. Date of collection is required.
2. Ordering healthcare professional name and phone number are required.
Specimen Required
Two separate EDTA whole blood specimens are required: 1 refrigerate and 1 ambient transport temperature.
For serial monitoring, it is recommended that specimens are collected at the same time of day.
Specimen Type: Whole blood for TBBS / Quantitative Lymphocyte Subsets: T, B, and Natural Killer (NK) Cells, Blood
Container/Tube: 4 mL Lavender top (EDTA)
Specimen Volume: 3 mL
Collection Instructions:
1. Send whole blood specimen in original tube. Do not aliquot.
2. Label specimen as TBBS.
3. Ship ambient.
Specimen Stability Information: Ambient <52 hours
Specimen Type: Whole blood for IABC / B-Cell Phenotyping Screen for Immunodeficiency and Immune Competence Assessment, Blood
Container/Tube: Lavender top (EDTA)
Specimen Volume:
≤14 years: 4 mL
>14 years: 10 mL
Collection Instructions:
1. Send whole blood specimen in original tube. Do not aliquot.
2. Label specimen IABC.
3. Ship refrigerate.
Specimen Stability Information: Refrigerated <48 hours
Specimen Minimum Volume
TBBS: 1 mL; IABC: > 14 years: 5 mL; ≤ 14 years: 3 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Whole Blood EDTA | Varies | 48 hours | PURPLE OR PINK TOP/EDTA |
Reference Values
The appropriate age-related reference values will be provided on the report.
Day(s) Performed
Monday through Friday
Performing Laboratory
Mayo Clinic Laboratories in RochesterCPT Code Information
86355-B cells, total count
86357-Natural killer (NK) cells, total count
86359-T cells, total count
86360-Absolute CD4/CD8 count with ratio
86356 x7 - Mononuclear cell antigen, quantitative
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
IABCS | Immune Assessment B Cell Subsets, B | 90416-9 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
30296 | CD19+ % of total Lymphocytes | 8117-4 |
3321 | CD45 Total Lymph Count | 27071-0 |
3316 | % CD3 (T Cells) | 8124-0 |
29094 | CD20+ % of total Lymphocytes | 8119-0 |
3322 | CD3 (T Cells) | 8122-4 |
30298 | CD27+ % of CD19+ B cells | 89358-6 |
3319 | % CD4 (T Cells) | 8123-2 |
30300 | CD27+ IgM+ IgD+ % of CD19+ B cells | 89352-9 |
3325 | CD4 (T Cells) | 24467-3 |
30302 | CD27+ IgM- IgD- % of CD19+ B cells | 89350-3 |
3320 | % CD8 (T Cells) | 8101-8 |
30304 | CD27+ IgM+ IgD- % of CD19+ B cells | 89348-7 |
3326 | CD8 (T Cells) | 14135-8 |
30306 | IgM+ % of CD19+ B cells | 89346-1 |
3318 | % CD19 (B Cells) | 8117-4 |
30308 | CD38+ IgM- % of CD19+ B cells | 89344-6 |
30310 | CD38+ IgM+ % of CD19+ B cells | 89341-2 |
3324 | CD19 (B Cells) | 8116-6 |
4054 | % CD16+CD56 (NK cells) | 8112-5 |
30312 | CD21+ % of CD19+ B cells | 89356-0 |
30314 | CD21- % of CD19+ B cells | 89355-2 |
4055 | CD16+CD56 (NK cells) | 20402-4 |
3327 | 4/8 Ratio | 54218-3 |
30297 | CD19+ | 8116-6 |
29095 | CD20+ | 9558-8 |
6657 | Comment | 80722-2 |
30299 | CD27+ | 89353-7 |
30301 | CD27+ IgM+ IgD+ | 89351-1 |
30303 | CD27+ IgM- IgD- | 89349-5 |
30305 | CD27+ IgM+ IgD- | 89347-9 |
30307 | IgM+ | 89345-3 |
30309 | CD38+ IgM- | 89343-8 |
30311 | CD38+ IgM+ | 89357-8 |
30313 | CD21+ | 25164-5 |
30315 | CD21- | 89354-5 |
30316 | Interpretation | 80722-2 |
Test Classification
This test was developed using an analyte specific reagent. Its performance characteristics were determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the US Food and Drug Administration.Profile Information
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
TBBS | QN Lymphocyte Subsets: T, B, and NK | Yes | Yes |
IABC | Immune Assessment B Cell Subsets, B | No | Yes |
Testing Algorithm
When multiple specimen types are required to perform a panel of tests, the laboratory will perform the tests for which the appropriate specimen type was received. The laboratory will cancel those for which the appropriate specimen was not received. Be advised that this may change the degree of interpretation received with the report.
Report Available
3 to 4 daysNY State Approved
YesDisease States
- Common variable immunodeficiency